A STUDY TO COMPARE THE EFFECT OF COOLED RADIOFREQUENCY ABLATION AND INTRARTICULAR LOCAL ANAESTHETIC WITH STEROIDS FOR CHRONIC LOW BACK PAIN DUE TO SI JOINT PAI

Not Applicable

Conditions: Health Condition 1: M259- Joint disorder, unspecified

Registration Number: CTRI/2022/07/044143

Lead Sponsor: ESI INSTITUTE OF PAIN MANAGEMENT

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Chronic LBP of 3 monthsÃ¢â?¬• duration or longer

2. Absence of focal neurologic signs or symptoms, and at least 50% pain relief in numeric rating scale (NRS) following 1 fluoroscopically guided SI joint diagnostic block using 2 mL of local anaesthetic lignocaine 2%.

3. Patient aged between 20-60 years

4. Patient taking anti neuropathic medicine more than 6 weeks

5. Pain NRS Ã¢â?°Â¥5

6. SI joint diagnostic block confirmed patients

Exclusion Criteria

1. Patients not giving consent

2. Patients with a known, specific cause of LBP (e.g., spondylolisthesis or significant spinal stenosis), untreated coagulopathy, and concomitant comorbidity or psychiatric illness likelyto endanger the patient or compromise treatment outcomes.

3. Patients with severe fibromyalgia, cauda equina syndrome, severe paresis, severe acute pain.

4. History of spinal infection or surgery, deformity, pregnancy, lactation, severe trauma or fracture

5. On-going treatment with non-steroidal anti-inflammatory drugs

6. Body mass index of more than 30

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. To study and compare the effect of local anaesthetic with steroid and cooled radiofrequency ablation on pain relief (NRS). <br/ ><br>2. To study and compare the effect of local anaesthetic with steroid and cooled radiofrequency ablation on improvement in functional disability (Oswestry Disability Index).Timepoint: 1. Prior to injection preopertively <br/ ><br>2. Immediate postoperatively <br/ ><br>after injection <br/ ><br>3. 2 weeks after <br/ ><br>injection <br/ ><br>4. 4 weeks after <br/ ><br>injection <br/ ><br>5. 3 months after <br/ ><br>injection

Secondary Outcome Measures

Name	Time	Method
Any side effectsTimepoint: 1. Prior to injection preopertively <br/ ><br>2. Immediate postoperatively <br/ ><br>after injection <br/ ><br>3. 2 weeks after <br/ ><br>injection <br/ ><br>4. 4 weeks after <br/ ><br>injection <br/ ><br>5. 3 months after <br/ ><br>injection